SEC Form 4 · accession 0001144204-15-037191
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Dougherty
Director
Period of report
Jun 11, 2015
Accepted (ET)
Jun 15, 2015 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 20,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.60 | Jun 11, 2015 | A | 22,000 | A | — | Jun 11, 2025 | Common Stock | 22,000 | 22,000 | D |
Explanation of responses
- F1The options vests as follows: (i) 7,333 options vest on June 11, 2016; (ii) the remaining 14,667 shares vest in seven consecutive quarterly installments of 1,833 shares each on the 11th day of each respective month, beginning September 11, 2016 and continuing through March 11, 2018 with a final installment of 1,836 shares on June 11, 2018.